Cargando…
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
BACKGROUND: Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 0•85 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however...
Autores principales: | Ho, Hsiang-Ling, Wang, Fang-Yu, Lee, Hao-Ru, Huang, Ya-Lan, Lai, Chien-Liang, Jen, Wen-Chin, Hsieh, Shie-Liang, Chou, Teh-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546957/ https://www.ncbi.nlm.nih.gov/pubmed/34173603 http://dx.doi.org/10.1016/j.lanwpc.2020.100041 |
Ejemplares similares
-
Serologic Status for Pandemic (H1N1) 2009 Virus, Taiwan
por: Huang, Daniel Tsung-Ning, et al.
Publicado: (2011) -
A Large-Scale Seroprevalence of Epstein-Barr Virus in Taiwan
por: Chen, Chao-Yu, et al.
Publicado: (2015) -
765. Epidemiological And Clinical Features Of Rickettsiosis
por: Hammami, Fatma, et al.
Publicado: (2020) -
TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients
por: Fan, Wen-Chien, et al.
Publicado: (2016) -
Exam ref 70-765 provisioning SQL databases
por: D'Antoni, Joseph, et al.
Publicado: (2018)